{"id":"W3018431352","doi":"10.1016/s1474-4422(20)30071-5","title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","year":2020,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1360,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"European Research Council; Fonds de Recherche du Québec - Santé; Montreal Neurological Institute and Hospital; University Hospital Foundation; Wallenberg Centre for Molecular and Translational Medicine; Vetenskapsrådet; Hjärnfonden; GE Healthcare; Knut och Alice Wallenbergs Stiftelse; Lunds Universitet; Canada Foundation for Innovation; Alzheimer Society; Consortium canadien en neurodégénérescence associée au vieillissement; Alzheimer's Drug Discovery Foundation; Canadian Institutes of Health Research; Alzheimerfonden; Weston Brain Institute; Sahlgrenska Universitetssjukhuset; Roche; Marcus och Amalia Wallenbergs minnesfond; Parkinson Research Foundation; Association for Frontotemporal Degeneration","keywords":"Medicine; Biomarker; Cohort; Dementia; Prospective cohort study; Internal medicine; Oncology; Disease; Cohort study; Cognitive decline; Frontotemporal dementia; Alzheimer's disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}